EC approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors Read more
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca Read more
Hoth Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Read more
Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New England Journal of Medicine Read more